--------------------------------------------------------------------------------
                       SECURITIES AND EXCHANGE COMMISSION
                             Washington, D.C. 20549
--------------------------------------------------------------------------------

                                    FORM 8-K

                                 CURRENT REPORT
     PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

         Date of Report (Date of earliest event reported): May 19, 2004

                         SYNOVIS LIFE TECHNOLOGIES, INC.
             (Exact name of Registrant as specified in its charter)

                        State of Incorporation: Minnesota
                 I.R.S. Employer Identification No.: 41-1526554

         Address of principal executive offices: 2575 University Ave. W.
                                                St. Paul, Minnesota 55114

                        Telephone Number: (651) 603-3700

               ---------------------------------------------------



ITEM 7. FINANCIAL STATEMENTS AND EXHIBITS.

      (c) Exhibits.

            (99.1) Transcript of Synovis Life Technologies, Inc. May 19, 2004
conference call.

ITEM 12. RESULTS OF OPERATIONS AND FINANCIAL CONDITION

On May 19, 2004, Synovis Life Technologies, Inc. (Synovis) held a conference
call to discuss its financial results for the three and six months ended April
30, 2004, as well as current market opportunities and the outlook for the
remainder of fiscal 2004. A transcript of the conference call is attached hereto
as Exhibit 99.1, and is furnished in accordance with Item 12 of Form 8-K. In
accordance with General Instruction B.6. of Form 8-K, all of the information in
this Item and the accompanying exhibit shall not be deemed to be "filed" for the
purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the
"Exchange Act"), and shall not be deemed to be incorporated by reference in any
filing under the Securities Act of 1933, as amended, or the Exchange Act.

                                    SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the
Registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.

                                   SYNOVIS LIFE TECHNOLOGIES, INC.

                                   By: /s/ Connie L. Magnuson
                                       -----------------------------------------
May 25, 2004                           Connie L. Magnuson
                                       Vice-President of Finance, Chief
                                       Financial Officer and Corporate Secretary